XML 17 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2016
CNY (¥)
¥ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
CNY (¥)
¥ / shares
shares
Dec. 31, 2014
CNY (¥)
¥ / shares
shares
Revenues, net of business tax, value-added tax and related surcharges (including revenue from related party amounting to RMB1,194, RMB252 and RMB7,988 (US$1,151) for the years ended December 31, 2014, 2015 and 2016, respectively) ¥ 455,042 $ 65,540 ¥ 616,485 ¥ 606,883
Cost of revenues (286,543) (41,271) (353,336) (274,562)
Gross profit 168,499 24,269 263,149 332,321
Operating expenses:        
Selling expenses (70,093) (10,095) (112,815) (95,096)
General and administrative expenses (including consultation service fees to related party amounting to nil , RMB113 and RMB70 (US$10), for the years ended December 31, 2014, 2015 and 2016, respectively) (205,908) (29,657) (132,952) (53,576)
Impairment of long-lived assets (61,124) (8,804) (23,125)
Operating income (loss) (168,626) (24,287) (5,743) 183,649
Interest expense (including interest expense to related party amounting to nil, 6,705 and RMB15,073 (US$2,171) for the years ended December 31, 2014, 2015 and 2016, respectively) (89,327) (12,866) (53,214) (53,470)
Foreign exchange gain 13,472 1,940 10,348 9,585
Loss from disposal of property, plant and equipment (7,619) (1,097) (4,220) (3,955)
Interest income 27,982 4,030 22,447 21,208
Changes in fair value of derivative 713 103 33,731 2,605
Loss on debt extinguishment (36,648)
Income (loss) from equity method investments 616 89 (5,572) 13,911
Other income, net 18,191 2,620 33,617 2,113
Income (loss) from continuing operations before income tax (204,598) (29,468) (5,254) 175,646
Income tax expenses (60,486) (8,712) (74,025) (80,850)
Net income (loss) from continuing operations (265,084) (38,180) (79,279) 94,796
Net income from discontinued operations 25,476
Net income (loss) (265,084) (38,180) (79,279) 120,272
Net loss attributable to noncontrolling interests (3,217) (463) (975) (4,437)
Net income (loss) attributable to Concord Medical Services Holdings Limited ¥ (261,867) $ (37,717) ¥ (78,304) ¥ 124,709
Earnings(loss) per share        
From continuing operations | (per share) ¥ (2.00) $ (0.29) ¥ (0.58) ¥ 0.7
From discontinued operations | (per share) 0.22
Income (loss) per share - basic | (per share) (2.00) (0.29) (0.58) 0.92
From continuing operations | (per share) (2.00) (0.29) (0.58) 0.7
From discontinued operations | (per share) 0.22
Income (loss) per share - diluted | (per share) ¥ (2.00) $ (0.29) ¥ (0.58) ¥ 0.92
Weighted average number of shares outstanding:        
Basic 130,631,867 130,631,867 134,546,772 134,836,300
Diluted 130,631,867 130,631,867 134,546,772 135,180,642
Other comprehensive loss, net of tax        
Foreign currency translation ¥ (41,394) $ (5,962) ¥ (27,923) ¥ (3,368)
Total other comprehensive loss, net of tax (41,394) (5,962) (27,923) (3,368)
Comprehensive income (loss) (306,478) (44,142) (107,202) 116,904
Comprehensive loss attributable to noncontrolling interests (6,740) (971) (975) (4,437)
Comprehensive income (loss) attributable to Concord Medical Services Holdings Limited ¥ (299,738) $ (43,171) ¥ (106,227) ¥ 121,341